HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers

By Toh U.   Yamana H.   Nakao M.   Imai Y.   Seki N.   Takasu H.   Kaneshige T.   Fujita H.   Shirouzu K.   Itoh K.  

Cellular Immunology, Vol. 177, Iss. 2, 1997-05 ,pp. : 137-143

Academic Press

Access to resources Recommend Favorite

Recognition of gp43 Tumor-Associated Antigen Peptide by both HLA-A2 Restricted CTL Lines and Antibodies from Melanoma Patients

By Takahashi T.   Irie R.F.   Morton D.L.   Hoon D.S.B.  

Cellular Immunology, Vol. 178, Iss. 2, 1997-06 ,pp. : 162-171

Academic Press

Access to resources Recommend Favorite

Repression of Interleukin-2 mRNA Translation in Primary Human Breast Carcinoma Tumor-Infiltrating Lymphocytes

By Lopez C.B.   Rao T.D.   Feiner H.   Shapiro R.   Marks J.R.   Frey A.B.  

Cellular Immunology, Vol. 190, Iss. 2, 1998-12 ,pp. : 141-155

Academic Press

Access to resources Recommend Favorite

Antigen Presentation of a Modified Tumor-Derived Peptide by Tumor Infiltrating Lymphocytes

By Dionne S.O.   Smith M.H.   Marincola F.M.   Lake D.F.  

Cellular Immunology, Vol. 214, Iss. 2, 2001-12 ,pp. : 139-144

Academic Press

Access to resources Recommend Favorite

Cytotoxic Properties of CD4⁺ T-Cell Clones Which Lyse HLA Class II Negative Autologous Non-Small-Cell Lung Cancer Cells

By Semino C.   Ferlazzo G.   Ratto G.B.   Melioli G.  

Cellular Immunology, Vol. 196, Iss. 2, 1999-09 ,pp. : 87-94

Academic Press

Access to resources Recommend Favorite